Details for New Drug Application (NDA): 018799

✉ Email this page to a colleague

NDA 018799 describes PRALIDOXIME CHLORIDE, which is a drug marketed by Baxter Hlthcare Corp and Meridian Medcl Techn and is included in two NDAs. Additional details are available on the PRALIDOXIME CHLORIDE profile page.

The generic ingredient in PRALIDOXIME CHLORIDE is pralidoxime chloride. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pralidoxime chloride profile page.

Summary for 018799

Tradename:	PRALIDOXIME CHLORIDE
Applicant:	Baxter Hlthcare Corp
Ingredient:	pralidoxime chloride
Patents:	0

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	300MG/ML
Approval Date:	Dec 13, 1982	TE:		RLD:	No

Expired US Patents for NDA 018799

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	PRALIDOXIME CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	018799-001	Dec 13, 1982	⤷ Subscribe	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.